Thursday, December 13, 2018 2:46:34 PM
it's tax loss selling season, and forced selling is no doubt part of the downdraft today.
stock also broke down through an 8-mo uptrend.
http://bigcharts.marketwatch.com/quickchart/quickchart.asp?symb=MRMD&insttype=Stock&freq=1&show=&time=8
shs o/s have increased rapidly over the past two years from 64mm end of 2016 to 177mm end of 2017 to 203mm as of 9-30-18.
operating cash burn was about $20mm in 2017 and about $10mm during 3q18.
the good news .. maybe? today looks a puke selling day on what will end up being the highest down volume day in the stock's publicly-traded history.
Recent MRMD News
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 03/11/2024 09:30:47 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 03/11/2024 09:05:01 PM
- Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405] • Edgar (US Regulatory) • 03/07/2024 09:02:55 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 03/06/2024 10:06:10 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 11/20/2023 10:03:37 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 11/09/2023 09:11:11 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 11/09/2023 09:07:54 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 11/08/2023 10:06:50 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 11/03/2023 11:35:02 AM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 10/30/2023 09:24:42 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 10/30/2023 09:17:46 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 09/06/2023 10:29:20 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 08/04/2023 06:45:17 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 08/02/2023 09:13:09 PM
NanoViricides Reports that the Phase I NV-387 Clinical Trial is Completed Successfully and Data Lock is Expected Soon • NNVC • May 2, 2024 10:07 AM
ILUS Files Form 10-K and Provides Shareholder Update • ILUS • May 2, 2024 8:52 AM
Avant Technologies Names New CEO Following Acquisition of Healthcare Technology and Data Integration Firm • AVAI • May 2, 2024 8:00 AM
Bantec Engaged in a Letter of Intent to Acquire a Small New Jersey Based Manufacturing Company • BANT • May 1, 2024 10:00 AM
Cannabix Technologies to Deliver Breath Logix Alcohol Screening Device to Australia • BLO • Apr 30, 2024 8:53 AM
Hydromer, Inc. Reports Preliminary Unaudited Financial Results for First Quarter 2024 • HYDI • Apr 29, 2024 9:10 AM